| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.10B | 10.92B | 10.90B | 10.53B | 11.88B | 11.01B |
| Gross Profit | 6.00B | 5.78B | 5.93B | 6.08B | 6.73B | 6.48B |
| EBITDA | 1.53B | 1.47B | 84.16M | 1.12B | 1.36B | 1.18B |
| Net Income | 663.90M | 591.63M | -628.79M | 510.09M | 715.41M | 829.92M |
Balance Sheet | ||||||
| Total Assets | 10.98B | 11.42B | 10.87B | 11.44B | 8.87B | 8.21B |
| Cash, Cash Equivalents and Short-Term Investments | 5.04B | 4.92B | 4.36B | 3.61B | 3.62B | 3.62B |
| Total Debt | 600.00M | 1.19B | 1.48B | 1.57B | 209.15M | 0.00 |
| Total Liabilities | 8.61B | 9.03B | 9.06B | 8.75B | 5.92B | 5.67B |
| Stockholders Equity | 2.37B | 2.39B | 1.81B | 2.69B | 2.93B | 2.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 901.23M | 1.38B | -708.88M | 338.84M | 892.51M |
| Operating Cash Flow | 0.00 | 1.21B | 1.78B | -213.40M | 669.08M | 1.25B |
| Investing Cash Flow | 0.00 | -292.00M | -325.63M | -510.15M | -278.35M | -5.65M |
| Financing Cash Flow | 0.00 | -361.39M | -702.63M | 712.28M | -392.52M | -78.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥6.44B | 16.25 | ― | 1.17% | 6.95% | -9.62% | |
76 Outperform | ¥10.70B | 24.36 | ― | 0.46% | 19.35% | 71.74% | |
76 Outperform | ¥27.07B | 19.25 | ― | 4.27% | 21.97% | 15.89% | |
76 Outperform | ¥12.20B | 15.02 | ― | 2.40% | 2.75% | 25.24% | |
66 Neutral | ¥28.82B | 21.61 | ― | ― | 6.33% | 14.82% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | ¥133.33B | 83.34 | ― | 0.12% | 36.42% | 28.23% |
GMO Pepabo, Inc. reported a 1.9% increase in net sales for the nine months ending September 30, 2025, with significant growth in profit attributable to owners of the parent, which rose by 37.7%. The company also announced a revision in its dividend forecast, indicating a higher year-end dividend for 2025, which includes a special dividend, reflecting its strong financial performance and commitment to shareholder returns.
The most recent analyst rating on (JP:3633) stock is a Buy with a Yen2295.00 price target. To see the full list of analyst forecasts on GMO Pepabo, Inc. stock, see the JP:3633 Stock Forecast page.